← Every applicant
Jiangsu Hansoh Pharm FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| AZACITIDINENew drugJun 28, 2023POWDER, INTRAVENOUS, SUBCUTANEOUS |
| BORTEZOMIBNew drugJul 26, 2022INJECTABLE, INTRAVENOUS, SUBCUTANEOUS |
| PEMETREXED DISODIUMNew drugMay 25, 2022POWDER, INTRAVENOUS |
| DECITABINENew drugApr 15, 2022INJECTABLE, INTRAVENOUS |
| FULVESTRANTNew drugFeb 10, 2022SOLUTION, INTRAMUSCULAR |
| MICAFUNGIN SODIUMNew drugJul 9, 2021INJECTABLE, INTRAVENOUS |